Amarin Corporation News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.03.22	Amarin Receives Reimbursement for VAZKEPA® in Sweden (GlobeNewswire)
15.03.22	Jüngste Analysen zeigen, dass VASCEPA® (Icosapent-Ethyl) das Risiko potenziell tödlicher kardiovaskulärer Ereignisse bei Patienten mit vorheriger perkutaner Koronarintervention signifikant gesenkt hat (GlobeNewswire)
10.03.22	Latest analysis shows VASCEPA® (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention (GlobeNewswire)
15.12.21	ROSEN, A LEADING LAW FIRM, Encourages Amarin Corporation plc Investors with Losses in Excess of $100K to Secure Counsel Before Important December 23 Deadline in Securities Class Action - AMRN (PR Newswire)
06.11.21	ROSEN, A TOP RANKED LAW FIRM, Encourages Amarin Corporation plc Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - AMRN (PR Newswire)
29.10.21	ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Amarin Corporation plc Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - AMRN (PR Newswire)
07.01.21	Amarin Preliminary 2020 Revenue Up Approximately 42% - Quick Facts (RTTNews)
20.11.20	Pre-market Movers In Healthcare Sector: TTNP, AMRN, MESO, OGEN, PSTV… (RTTNews)
16.10.20	Pre-market Movers In Healthcare Sector: RWLK, ETTX, AMRN, CEMI... (RTTNews)
03.09.20	AGTC Abuzz, AMRN Slumps & CORT Soars As Oral Arguments Commence, FLGT Gears Up, NNVC On Watch (RTTNews)
31.08.20	Pre-market Movers In Healthcare Sector: AIMT, HUGE, AMRN, EVFM, LPCN... (RTTNews)
17.08.20	Präsentation der aktuellen klinischen Forschung zur Beurteilung von VASCEPA® (Icosapent-Ethyl) bei Patienten mit kardiovaskulärem Restrisiko beim ESC-Kongress 2020 (Jahrestagung der Europäischen Gesel (GlobeNewswire)
17.08.20	Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Residual Cardiovascular Risk to be Presented at ESC Congress 2020, the Annual Meeting of the European Society of Cardiol (GlobeNewswire)
06.08.20	Amarin kündigt Pläne zur Maximierung des Blockbuster-Potenzials von VASCEPA® (Icosapent-Ethyl) in Europa an (GlobeNewswire)
04.08.20	Amarin Announces Plans to Maximize Blockbuster Potential of VASCEPA® (icosapent ethyl) in Europe (GlobeNewswire)
17.06.20	AMRN Makes Peace With Apotex, IDYA Cuts Deal With GSK, SLRX On Watch, NBIX, TAK Ink $2Bln Pact (RTTNews)
22.05.20	FDA Approves First Generic Version Of Vascepa; Amarin On Watch (RTTNews)
14.04.20	AMRN Chugs Along, ATHX To Initiate Pivotal COVID-19 Trial, WORX Soars 550% (RTTNews)
02.04.20	What's The Buzz About Amarin Corp. (AMRN)? (RTTNews)
31.03.20	AMRN Loses Legal Fight, AKRO Awaits Big Day, JNJ's Covid-19 Vaccine Study In Sep (RTTNews)
14.12.19	Are These Biotech Companies Buyout Candidates? Deal Or No Deal? (RTTNews)
14.12.19	Amarin's Vascepa Gets FDA Approval For Expanded Use, Shares Up 5% (RTTNews)
03.12.19	Europäischen Arzneimittelagentur akzeptiert Prüfung des Antrags auf Genehmigung für das Inverkehrbringen von Amarins Icosapent-Ethyl (Vascepa®) zur Reduzierung des kardiovaskulären Risikos für Hochris (GlobeNewswire)
02.12.19	European Medicines Agency Accepts for Review Marketing Authorization Application for Amarin’s Icosapent Ethyl (Vascepa®) for Reduction of Cardiovascular Risk in High-Risk Patients, as Reflected in RED (GlobeNewswire)
02.12.19	Biotech Stocks Facing FDA Decision In December 2019 (RTTNews)
13.11.19	Today's Top 5 Gainers In Healthcare Sector (AMRN, DMAC, TNXP...) (RTTNews)
28.10.19	Biotech Stocks Facing FDA Decision In November 2019 (RTTNews)
03.09.19	New 2019 Updates to the European Society of Cardiology’s and European Atherosclerosis Society’s Guidelines for the Management of Dyslipidaemias Incorporate Findings from the REDUCE-IT™ Cardiovascular (GlobeNewswire)
09.08.19	FDA To Hold Advisory Committee Hearing For Amarin's Vascepa SNDA, Stock Fall 22% (RTTNews)
01.08.19	AMRN'S Vascepa Hits Record Sales, ADMP Slumps On Stock Offering, SRDX On Watch… (RTTNews)
03.07.19	6 Top Gainers In Healthcare Sector (AMRN, DOVA, IMUX...) (RTTNews)
11.01.19	6 Top Gainers In Healthcare Sector (PLXP, AMRN, MRTX...) (RTTNews)
12.11.18	Vascepa Vs Placebo: AMRN Stands Behind REDUCE-IT Results (RTTNews)
12.10.18	ATXI Abuzz, CRMD On Watch, AMRN Back In Focus (RTTNews)
29.09.18	Week Ahead In Pharmaceuticals: 5 Stocks To Watch (OMER, BOLD, XLRN...) (RTTNews)
25.09.18	AMRN Heartens Investors, AKCA On Watch, ACRX Faces FDA Panel In Oct. (RTTNews)
24.09.18	Amarin: Cardiovascular Outcomes Study Of Vascepa Capsules Met Primary Endpoint (RTTNews)
22.09.18	Week Ahead In Pharmaceuticals: 10 Stocks To Watch (CKPT, SNDX, ADMP...) (RTTNews)
27.08.18	BGNE On Watch, AMRN Gears Up For Big Event, ZLAB Discontinues ZL-3101 (RTTNews)
29.06.18	QURE Exudes Hope, ZFGN Catches Eyes, NDRA On Watch, XENE Hits New High (RTTNews)
24.01.18	AMRN Looks Forward To Big Event, PBYI Plunges After-hours, SPARC Lights Up CERS (RTTNews)
05.01.18	Amarin Pulls Back Off Best Levels But Remains Firmly Positive (RTTNews)
05.01.18	EARS Down But Not Out, Major Event Awaits AMRN In Q3, Exciting Time For TTOO (RTTNews)
21.12.17	VYGR Sails Ahead, SGYP Awaits FDA Decision, AMRN Readies For Landmark Trial Data (RTTNews)
23.08.17	Technical Snapshots for These Drug Makers Stocks -- Teva Pharma, Endo, Ionis Pharma, and Amarin (PR Newswire)
18.07.17	Technical Reports on Drug Makers Equities -- Teva Pharma, Endo, Ionis Pharma, and Amarin (PR Newswire)
11.07.17	Asset Acquisitions Accelerate in Healthcare Sector Boosting Potential Revenue Growth (PR Newswire)
11.07.17	Asset Acquisitions Accelerate in Healthcare Sector Boosting Potential Revenue Growth (PR Newswire)
15.06.17	Technical Snapshots for These Drug Makers Stocks -- Endo, Teva Pharma, Ionis Pharma, and Amarin (PR Newswire)
04.05.17	Drug Makers Stocks Under Scanner -- Teva Pharma, Endo, Ionis Pharma, and Amarin (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	28.46	2.63 %	K V
Swiss Life Hldg	712.60	1.86 %	K V
Part Grp Hldg	1’245.50	1.26 %	K V
Zurich Insur Gr	545.00	1.15 %	K V
Swiss Re	132.70	1.14 %	K V
Givaudan	3’945.00	-0.53 %	K V
Geberit	511.20	-0.66 %	K V
Alcon	76.38	-0.68 %	K V
Sika	212.90	-1.34 %	K V
CieFinRichemont	134.25	-2.65 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Amarin Corporation PLC (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten